Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ssAAV2-GFP is a single-stranded adeno-associated virus serotype 2 (AAV2) vector engineered to deliver the gene encoding Green Fluorescent Protein (GFP). AAV2 vectors are commonly used in gene therapy research due to their ability to efficiently transduce a wide range of cell types and maintain long-term transgene expression. GFP is a reporter protein that emits green fluorescence, making ssAAV2-GFP a valuable tool for studying gene transfer, expression patterns, and viral vector trafficking in various biological systems, particularly in ocular gene therapy studies. It is not typically used as a therapeutic agent itself, as GFP does not exert a direct therapeutic effect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ssAAV2-GFP.